Ken Griffin's position in Novo Nordisk - ADR is currently worth $68.6 Million. That's 0.07% of their equity portfolio (361st largest holding). The first Novo Nordisk - ADR trade was made in Q3 2014. Since then Ken Griffin bought shares 50 more times and sold shares on 44 occasions. The stake costed the investor $37 Million, netting the investor a gain of 85% so far.